Yoosakul E, Seeduang C, Chuasuwan B, Manamuti C, Pitisuttithum P, Karachot B, Techatanawat I. Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Irbesartan Formulation, Irbesartan GPO 150 mg Tablets and Aprovel® 150 mg Tablets, after Oral Administration to Healthy Thai Volunteers under Fasti. J Health Res [Internet]. 2017 Feb. 21 [cited 2024 May 8];30(3):199-205. Available from: https://he01.tci-thaijo.org/index.php/jhealthres/article/view/77939